β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients

Lo Y.-W.Lee A.Y.-L.Liu Y.-C.HUI-HSIN KOPeng H.-H.Hsiang-Chieh LeePan P.-Y.CHUN-PIN CHIANGSHIH-JUNG CHENG2021-07-072021-07-0720221354-523Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85102475600&doi=10.1111%2fodi.13827&partnerID=40&md5=2f98a1aa374d16ef69b20ebbd7d95015https://scholars.lib.ntu.edu.tw/handle/123456789/570374[SDGs]SDG3β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patientsjournal article10.1111/odi.13827336555732-s2.0-85102475600